nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—autistic disorder—Clonidine—glaucoma	0.499	1	CpDpCtD
Sertraline—SLC6A2—Clonidine—glaucoma	0.0322	0.108	CbGbCtD
Sertraline—CYP2D6—Carteolol—glaucoma	0.0261	0.0871	CbGbCtD
Sertraline—CYP1A2—Betaxolol—glaucoma	0.0214	0.0714	CbGbCtD
Sertraline—CYP2D6—Betaxolol—glaucoma	0.0176	0.0588	CbGbCtD
Sertraline—CYP2C19—Methazolamide—glaucoma	0.0176	0.0586	CbGbCtD
Sertraline—CYP2C9—Diclofenamide—glaucoma	0.017	0.0566	CbGbCtD
Sertraline—CYP2C9—Dorzolamide—glaucoma	0.0164	0.0547	CbGbCtD
Sertraline—CYP2C19—Timolol—glaucoma	0.0149	0.0499	CbGbCtD
Sertraline—CYP2C9—Methazolamide—glaucoma	0.0146	0.0488	CbGbCtD
Sertraline—CYP2D6—Methazolamide—glaucoma	0.0133	0.0446	CbGbCtD
Sertraline—CYP3A4—Pilocarpine—glaucoma	0.0126	0.042	CbGbCtD
Sertraline—ABCB1—Timolol—glaucoma	0.012	0.0402	CbGbCtD
Sertraline—CYP1A2—Clonidine—glaucoma	0.0117	0.0391	CbGbCtD
Sertraline—CYP2D6—Timolol—glaucoma	0.0114	0.0379	CbGbCtD
Sertraline—ABCB1—Clonidine—glaucoma	0.0102	0.0342	CbGbCtD
Sertraline—CYP3A4—Brinzolamide—glaucoma	0.00986	0.0329	CbGbCtD
Sertraline—CYP2D6—Clonidine—glaucoma	0.00965	0.0322	CbGbCtD
Sertraline—CYP3A4—Dorzolamide—glaucoma	0.00952	0.0318	CbGbCtD
Sertraline—CYP3A4—Methazolamide—glaucoma	0.00849	0.0283	CbGbCtD
Sertraline—CYP3A4—Acetazolamide—glaucoma	0.00679	0.0227	CbGbCtD
Sertraline—CYP3A4—Clonidine—glaucoma	0.00614	0.0205	CbGbCtD
Sertraline—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	6.61e-05	0.00221	CbGpPWpGaD
Sertraline—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.6e-05	0.00221	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—NTRK1—glaucoma	6.57e-05	0.0022	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—NGF—glaucoma	6.54e-05	0.00219	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—SLC6A1—glaucoma	6.54e-05	0.00219	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	6.51e-05	0.00218	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	6.43e-05	0.00215	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—GSTM1—glaucoma	6.38e-05	0.00213	CbGpPWpGaD
Sertraline—Alopecia—Betaxolol—glaucoma	6.35e-05	0.000369	CcSEcCtD
Sertraline—Palpitations—Clonidine—glaucoma	6.35e-05	0.000369	CcSEcCtD
Sertraline—Gastrointestinal disorder—Pilocarpine—glaucoma	6.34e-05	0.000368	CcSEcCtD
Sertraline—Gastrointestinal pain—Travoprost—glaucoma	6.33e-05	0.000367	CcSEcCtD
Sertraline—Loss of consciousness—Clonidine—glaucoma	6.31e-05	0.000367	CcSEcCtD
Sertraline—Feeling abnormal—Brinzolamide—glaucoma	6.29e-05	0.000365	CcSEcCtD
Sertraline—Mental disorder—Betaxolol—glaucoma	6.29e-05	0.000365	CcSEcCtD
Sertraline—Pain—Pilocarpine—glaucoma	6.28e-05	0.000364	CcSEcCtD
Sertraline—Constipation—Pilocarpine—glaucoma	6.28e-05	0.000364	CcSEcCtD
Sertraline—Cough—Clonidine—glaucoma	6.27e-05	0.000364	CcSEcCtD
Sertraline—Sweating—Timolol—glaucoma	6.27e-05	0.000364	CcSEcCtD
Sertraline—Dizziness—Apraclonidine—glaucoma	6.27e-05	0.000364	CcSEcCtD
Sertraline—Erythema—Betaxolol—glaucoma	6.25e-05	0.000363	CcSEcCtD
Sertraline—Malnutrition—Betaxolol—glaucoma	6.25e-05	0.000363	CcSEcCtD
Sertraline—Urticaria—Dorzolamide—glaucoma	6.17e-05	0.000358	CcSEcCtD
Sertraline—Epistaxis—Timolol—glaucoma	6.17e-05	0.000358	CcSEcCtD
Sertraline—Abdominal pain—Dorzolamide—glaucoma	6.14e-05	0.000357	CcSEcCtD
Sertraline—Body temperature increased—Dorzolamide—glaucoma	6.14e-05	0.000357	CcSEcCtD
Sertraline—Tension—Betaxolol—glaucoma	6.14e-05	0.000356	CcSEcCtD
Sertraline—Sinusitis—Timolol—glaucoma	6.13e-05	0.000356	CcSEcCtD
Sertraline—Dysgeusia—Betaxolol—glaucoma	6.12e-05	0.000356	CcSEcCtD
Sertraline—Arthralgia—Clonidine—glaucoma	6.12e-05	0.000355	CcSEcCtD
Sertraline—Chest pain—Clonidine—glaucoma	6.12e-05	0.000355	CcSEcCtD
Sertraline—Abdominal pain—Travoprost—glaucoma	6.12e-05	0.000355	CcSEcCtD
Sertraline—Agranulocytosis—Timolol—glaucoma	6.1e-05	0.000354	CcSEcCtD
Sertraline—Anxiety—Clonidine—glaucoma	6.09e-05	0.000354	CcSEcCtD
Sertraline—Asthenia—Acetazolamide—glaucoma	6.08e-05	0.000353	CcSEcCtD
Sertraline—SLC6A3—Neuronal System—SLC6A1—glaucoma	6.08e-05	0.00203	CbGpPWpGaD
Sertraline—Dizziness—Bimatoprost—glaucoma	6.08e-05	0.000353	CcSEcCtD
Sertraline—Nervousness—Betaxolol—glaucoma	6.07e-05	0.000353	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	6.07e-05	0.000353	CcSEcCtD
Sertraline—Urticaria—Brinzolamide—glaucoma	6.07e-05	0.000352	CcSEcCtD
Sertraline—Feeling abnormal—Pilocarpine—glaucoma	6.05e-05	0.000351	CcSEcCtD
Sertraline—Discomfort—Clonidine—glaucoma	6.04e-05	0.000351	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—BDNF—glaucoma	6.04e-05	0.00202	CbGpPWpGaD
Sertraline—Vomiting—Apraclonidine—glaucoma	6.02e-05	0.00035	CcSEcCtD
Sertraline—Muscle spasms—Betaxolol—glaucoma	6.01e-05	0.000349	CcSEcCtD
Sertraline—Gastrointestinal pain—Pilocarpine—glaucoma	6e-05	0.000349	CcSEcCtD
Sertraline—Hypersensitivity—Brimonidine—glaucoma	5.99e-05	0.000348	CcSEcCtD
Sertraline—Dry mouth—Clonidine—glaucoma	5.98e-05	0.000347	CcSEcCtD
Sertraline—Bradycardia—Timolol—glaucoma	5.97e-05	0.000347	CcSEcCtD
Sertraline—Dermatitis—Apraclonidine—glaucoma	5.97e-05	0.000347	CcSEcCtD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.95e-05	0.00199	CbGpPWpGaD
Sertraline—Headache—Apraclonidine—glaucoma	5.94e-05	0.000345	CcSEcCtD
Sertraline—Confusional state—Clonidine—glaucoma	5.91e-05	0.000343	CcSEcCtD
Sertraline—Rhinitis—Timolol—glaucoma	5.88e-05	0.000342	CcSEcCtD
Sertraline—MAOA—Metabolism—CA5A—glaucoma	5.87e-05	0.00196	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NARFL—glaucoma	5.87e-05	0.00196	CbGpPWpGaD
Sertraline—Oedema—Clonidine—glaucoma	5.86e-05	0.00034	CcSEcCtD
Sertraline—Tremor—Betaxolol—glaucoma	5.86e-05	0.00034	CcSEcCtD
Sertraline—Hallucination—Timolol—glaucoma	5.84e-05	0.000339	CcSEcCtD
Sertraline—Asthenia—Brimonidine—glaucoma	5.84e-05	0.000339	CcSEcCtD
Sertraline—Abdominal pain—Pilocarpine—glaucoma	5.8e-05	0.000337	CcSEcCtD
Sertraline—Body temperature increased—Pilocarpine—glaucoma	5.8e-05	0.000337	CcSEcCtD
Sertraline—Ill-defined disorder—Betaxolol—glaucoma	5.8e-05	0.000337	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL1A—glaucoma	5.8e-05	0.00194	CbGpPWpGaD
Sertraline—Diarrhoea—Acetazolamide—glaucoma	5.8e-05	0.000337	CcSEcCtD
Sertraline—Rash—Bimatoprost—glaucoma	5.79e-05	0.000336	CcSEcCtD
Sertraline—Dermatitis—Bimatoprost—glaucoma	5.79e-05	0.000336	CcSEcCtD
Sertraline—Oedema peripheral—Timolol—glaucoma	5.78e-05	0.000336	CcSEcCtD
Sertraline—Anaemia—Betaxolol—glaucoma	5.78e-05	0.000336	CcSEcCtD
Sertraline—Shock—Clonidine—glaucoma	5.77e-05	0.000335	CcSEcCtD
Sertraline—Connective tissue disorder—Timolol—glaucoma	5.77e-05	0.000335	CcSEcCtD
Sertraline—Pruritus—Brimonidine—glaucoma	5.76e-05	0.000334	CcSEcCtD
Sertraline—Headache—Bimatoprost—glaucoma	5.76e-05	0.000334	CcSEcCtD
Sertraline—Nervous system disorder—Clonidine—glaucoma	5.75e-05	0.000334	CcSEcCtD
Sertraline—Thrombocytopenia—Clonidine—glaucoma	5.74e-05	0.000333	CcSEcCtD
Sertraline—Hypersensitivity—Dorzolamide—glaucoma	5.72e-05	0.000332	CcSEcCtD
Sertraline—Tachycardia—Clonidine—glaucoma	5.72e-05	0.000332	CcSEcCtD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.72e-05	0.00191	CbGpPWpGaD
Sertraline—Hypersensitivity—Travoprost—glaucoma	5.7e-05	0.000331	CcSEcCtD
Sertraline—Skin disorder—Clonidine—glaucoma	5.69e-05	0.000331	CcSEcCtD
Sertraline—Hyperhidrosis—Clonidine—glaucoma	5.67e-05	0.000329	CcSEcCtD
Sertraline—Visual impairment—Timolol—glaucoma	5.66e-05	0.000328	CcSEcCtD
Sertraline—SLC6A3—NRF2 pathway—GSTM1—glaucoma	5.65e-05	0.00189	CbGpPWpGaD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.64e-05	0.00189	CbGpPWpGaD
Sertraline—Malaise—Betaxolol—glaucoma	5.64e-05	0.000327	CcSEcCtD
Sertraline—Nausea—Apraclonidine—glaucoma	5.63e-05	0.000327	CcSEcCtD
Sertraline—Hypersensitivity—Brinzolamide—glaucoma	5.63e-05	0.000327	CcSEcCtD
Sertraline—Vertigo—Betaxolol—glaucoma	5.62e-05	0.000326	CcSEcCtD
Sertraline—Syncope—Betaxolol—glaucoma	5.61e-05	0.000326	CcSEcCtD
Sertraline—Dizziness—Acetazolamide—glaucoma	5.61e-05	0.000325	CcSEcCtD
Sertraline—Anorexia—Clonidine—glaucoma	5.59e-05	0.000324	CcSEcCtD
Sertraline—Asthenia—Dorzolamide—glaucoma	5.57e-05	0.000324	CcSEcCtD
Sertraline—Asthenia—Travoprost—glaucoma	5.55e-05	0.000322	CcSEcCtD
Sertraline—Palpitations—Betaxolol—glaucoma	5.53e-05	0.000321	CcSEcCtD
Sertraline—Pruritus—Dorzolamide—glaucoma	5.5e-05	0.000319	CcSEcCtD
Sertraline—Loss of consciousness—Betaxolol—glaucoma	5.5e-05	0.000319	CcSEcCtD
Sertraline—Eye disorder—Timolol—glaucoma	5.48e-05	0.000318	CcSEcCtD
Sertraline—Asthenia—Brinzolamide—glaucoma	5.48e-05	0.000318	CcSEcCtD
Sertraline—Hypotension—Clonidine—glaucoma	5.48e-05	0.000318	CcSEcCtD
Sertraline—Pruritus—Travoprost—glaucoma	5.47e-05	0.000318	CcSEcCtD
Sertraline—Tinnitus—Timolol—glaucoma	5.47e-05	0.000318	CcSEcCtD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.47e-05	0.00183	CbGpPWpGaD
Sertraline—Cough—Betaxolol—glaucoma	5.46e-05	0.000317	CcSEcCtD
Sertraline—Nausea—Bimatoprost—glaucoma	5.46e-05	0.000317	CcSEcCtD
Sertraline—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	5.46e-05	0.00182	CbGpPWpGaD
Sertraline—Cardiac disorder—Timolol—glaucoma	5.45e-05	0.000316	CcSEcCtD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.42e-05	0.00181	CbGpPWpGaD
Sertraline—Hypersensitivity—Pilocarpine—glaucoma	5.41e-05	0.000314	CcSEcCtD
Sertraline—Pruritus—Brinzolamide—glaucoma	5.4e-05	0.000314	CcSEcCtD
Sertraline—Vomiting—Acetazolamide—glaucoma	5.39e-05	0.000313	CcSEcCtD
Sertraline—Dizziness—Brimonidine—glaucoma	5.38e-05	0.000312	CcSEcCtD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	5.36e-05	0.00179	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—NGF—glaucoma	5.36e-05	0.00179	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Clonidine—glaucoma	5.34e-05	0.00031	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—NR3C1—glaucoma	5.34e-05	0.00178	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—GSTM1—glaucoma	5.33e-05	0.00178	CbGpPWpGaD
Sertraline—Angiopathy—Timolol—glaucoma	5.32e-05	0.000309	CcSEcCtD
Sertraline—Arthralgia—Betaxolol—glaucoma	5.32e-05	0.000309	CcSEcCtD
Sertraline—Chest pain—Betaxolol—glaucoma	5.32e-05	0.000309	CcSEcCtD
Sertraline—Myalgia—Betaxolol—glaucoma	5.32e-05	0.000309	CcSEcCtD
Sertraline—Diarrhoea—Dorzolamide—glaucoma	5.32e-05	0.000309	CcSEcCtD
Sertraline—Headache—Acetazolamide—glaucoma	5.31e-05	0.000308	CcSEcCtD
Sertraline—Anxiety—Betaxolol—glaucoma	5.31e-05	0.000308	CcSEcCtD
Sertraline—Insomnia—Clonidine—glaucoma	5.3e-05	0.000308	CcSEcCtD
Sertraline—Immune system disorder—Timolol—glaucoma	5.3e-05	0.000308	CcSEcCtD
Sertraline—Diarrhoea—Travoprost—glaucoma	5.29e-05	0.000307	CcSEcCtD
Sertraline—Mediastinal disorder—Timolol—glaucoma	5.29e-05	0.000307	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	5.29e-05	0.000307	CcSEcCtD
Sertraline—CYP1A2—Phase II conjugation—GSTT1—glaucoma	5.28e-05	0.00177	CbGpPWpGaD
Sertraline—Asthenia—Pilocarpine—glaucoma	5.27e-05	0.000306	CcSEcCtD
Sertraline—Paraesthesia—Clonidine—glaucoma	5.26e-05	0.000306	CcSEcCtD
Sertraline—Discomfort—Betaxolol—glaucoma	5.26e-05	0.000305	CcSEcCtD
Sertraline—CYP2B6—Biological oxidations—GSTT1—glaucoma	5.25e-05	0.00175	CbGpPWpGaD
Sertraline—Arrhythmia—Timolol—glaucoma	5.24e-05	0.000304	CcSEcCtD
Sertraline—Dyspnoea—Clonidine—glaucoma	5.23e-05	0.000303	CcSEcCtD
Sertraline—Diarrhoea—Brinzolamide—glaucoma	5.23e-05	0.000303	CcSEcCtD
Sertraline—Somnolence—Clonidine—glaucoma	5.21e-05	0.000303	CcSEcCtD
Sertraline—Dry mouth—Betaxolol—glaucoma	5.21e-05	0.000302	CcSEcCtD
Sertraline—Pruritus—Pilocarpine—glaucoma	5.19e-05	0.000302	CcSEcCtD
Sertraline—Alopecia—Timolol—glaucoma	5.19e-05	0.000301	CcSEcCtD
Sertraline—SLC6A4—Circadian rythm related genes—FAS—glaucoma	5.15e-05	0.00172	CbGpPWpGaD
Sertraline—Confusional state—Betaxolol—glaucoma	5.15e-05	0.000299	CcSEcCtD
Sertraline—Mental disorder—Timolol—glaucoma	5.14e-05	0.000299	CcSEcCtD
Sertraline—Dizziness—Dorzolamide—glaucoma	5.14e-05	0.000298	CcSEcCtD
Sertraline—Rash—Brimonidine—glaucoma	5.13e-05	0.000298	CcSEcCtD
Sertraline—Dermatitis—Brimonidine—glaucoma	5.12e-05	0.000298	CcSEcCtD
Sertraline—Dizziness—Travoprost—glaucoma	5.12e-05	0.000297	CcSEcCtD
Sertraline—Erythema—Timolol—glaucoma	5.11e-05	0.000297	CcSEcCtD
Sertraline—Malnutrition—Timolol—glaucoma	5.11e-05	0.000297	CcSEcCtD
Sertraline—Oedema—Betaxolol—glaucoma	5.1e-05	0.000296	CcSEcCtD
Sertraline—Headache—Brimonidine—glaucoma	5.1e-05	0.000296	CcSEcCtD
Sertraline—Decreased appetite—Clonidine—glaucoma	5.1e-05	0.000296	CcSEcCtD
Sertraline—Gastrointestinal disorder—Clonidine—glaucoma	5.06e-05	0.000294	CcSEcCtD
Sertraline—Fatigue—Clonidine—glaucoma	5.05e-05	0.000293	CcSEcCtD
Sertraline—Dizziness—Brinzolamide—glaucoma	5.05e-05	0.000293	CcSEcCtD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.04e-05	0.00168	CbGpPWpGaD
Sertraline—Nausea—Acetazolamide—glaucoma	5.03e-05	0.000292	CcSEcCtD
Sertraline—Diarrhoea—Pilocarpine—glaucoma	5.02e-05	0.000292	CcSEcCtD
Sertraline—Shock—Betaxolol—glaucoma	5.02e-05	0.000292	CcSEcCtD
Sertraline—Tension—Timolol—glaucoma	5.01e-05	0.000291	CcSEcCtD
Sertraline—Constipation—Clonidine—glaucoma	5.01e-05	0.000291	CcSEcCtD
Sertraline—Pain—Clonidine—glaucoma	5.01e-05	0.000291	CcSEcCtD
Sertraline—Nervous system disorder—Betaxolol—glaucoma	5.01e-05	0.000291	CcSEcCtD
Sertraline—Dysgeusia—Timolol—glaucoma	5e-05	0.00029	CcSEcCtD
Sertraline—Thrombocytopenia—Betaxolol—glaucoma	5e-05	0.00029	CcSEcCtD
Sertraline—Tachycardia—Betaxolol—glaucoma	4.98e-05	0.000289	CcSEcCtD
Sertraline—Nervousness—Timolol—glaucoma	4.96e-05	0.000288	CcSEcCtD
Sertraline—Skin disorder—Betaxolol—glaucoma	4.96e-05	0.000288	CcSEcCtD
Sertraline—Vomiting—Dorzolamide—glaucoma	4.94e-05	0.000287	CcSEcCtD
Sertraline—Hyperhidrosis—Betaxolol—glaucoma	4.93e-05	0.000286	CcSEcCtD
Sertraline—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	4.92e-05	0.00165	CbGpPWpGaD
Sertraline—Rash—Dorzolamide—glaucoma	4.9e-05	0.000284	CcSEcCtD
Sertraline—Dermatitis—Dorzolamide—glaucoma	4.89e-05	0.000284	CcSEcCtD
Sertraline—Rash—Travoprost—glaucoma	4.88e-05	0.000283	CcSEcCtD
Sertraline—Dermatitis—Travoprost—glaucoma	4.87e-05	0.000283	CcSEcCtD
Sertraline—Headache—Dorzolamide—glaucoma	4.87e-05	0.000283	CcSEcCtD
Sertraline—Anorexia—Betaxolol—glaucoma	4.87e-05	0.000282	CcSEcCtD
Sertraline—Vomiting—Brinzolamide—glaucoma	4.86e-05	0.000282	CcSEcCtD
Sertraline—Dizziness—Pilocarpine—glaucoma	4.85e-05	0.000282	CcSEcCtD
Sertraline—Headache—Travoprost—glaucoma	4.85e-05	0.000281	CcSEcCtD
Sertraline—Nausea—Brimonidine—glaucoma	4.83e-05	0.000281	CcSEcCtD
Sertraline—Feeling abnormal—Clonidine—glaucoma	4.83e-05	0.00028	CcSEcCtD
Sertraline—Rash—Brinzolamide—glaucoma	4.82e-05	0.00028	CcSEcCtD
Sertraline—Dermatitis—Brinzolamide—glaucoma	4.81e-05	0.000279	CcSEcCtD
Sertraline—Gastrointestinal pain—Clonidine—glaucoma	4.79e-05	0.000278	CcSEcCtD
Sertraline—Headache—Brinzolamide—glaucoma	4.78e-05	0.000278	CcSEcCtD
Sertraline—Hypotension—Betaxolol—glaucoma	4.77e-05	0.000277	CcSEcCtD
Sertraline—Angioedema—Timolol—glaucoma	4.67e-05	0.000271	CcSEcCtD
Sertraline—Vomiting—Pilocarpine—glaucoma	4.67e-05	0.000271	CcSEcCtD
Sertraline—Urticaria—Clonidine—glaucoma	4.66e-05	0.00027	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Betaxolol—glaucoma	4.65e-05	0.00027	CcSEcCtD
Sertraline—Abdominal pain—Clonidine—glaucoma	4.63e-05	0.000269	CcSEcCtD
Sertraline—Body temperature increased—Clonidine—glaucoma	4.63e-05	0.000269	CcSEcCtD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.63e-05	0.00155	CbGpPWpGaD
Sertraline—Rash—Pilocarpine—glaucoma	4.63e-05	0.000269	CcSEcCtD
Sertraline—Dermatitis—Pilocarpine—glaucoma	4.62e-05	0.000268	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—IL1A—glaucoma	4.62e-05	0.00154	CbGpPWpGaD
Sertraline—Insomnia—Betaxolol—glaucoma	4.62e-05	0.000268	CcSEcCtD
Sertraline—Nausea—Dorzolamide—glaucoma	4.61e-05	0.000268	CcSEcCtD
Sertraline—Headache—Pilocarpine—glaucoma	4.6e-05	0.000267	CcSEcCtD
Sertraline—Nausea—Travoprost—glaucoma	4.59e-05	0.000267	CcSEcCtD
Sertraline—Vertigo—Timolol—glaucoma	4.59e-05	0.000266	CcSEcCtD
Sertraline—Paraesthesia—Betaxolol—glaucoma	4.58e-05	0.000266	CcSEcCtD
Sertraline—Syncope—Timolol—glaucoma	4.58e-05	0.000266	CcSEcCtD
Sertraline—MAOB—Metabolism—CA1—glaucoma	4.57e-05	0.00153	CbGpPWpGaD
Sertraline—Dyspnoea—Betaxolol—glaucoma	4.55e-05	0.000264	CcSEcCtD
Sertraline—Nausea—Brinzolamide—glaucoma	4.54e-05	0.000263	CcSEcCtD
Sertraline—Palpitations—Timolol—glaucoma	4.51e-05	0.000262	CcSEcCtD
Sertraline—Dyspepsia—Betaxolol—glaucoma	4.49e-05	0.000261	CcSEcCtD
Sertraline—Loss of consciousness—Timolol—glaucoma	4.49e-05	0.000261	CcSEcCtD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.46e-05	0.00149	CbGpPWpGaD
Sertraline—Cough—Timolol—glaucoma	4.46e-05	0.000259	CcSEcCtD
Sertraline—Decreased appetite—Betaxolol—glaucoma	4.44e-05	0.000258	CcSEcCtD
Sertraline—MAOB—Metabolism—CTSA—glaucoma	4.42e-05	0.00148	CbGpPWpGaD
Sertraline—Hypertension—Timolol—glaucoma	4.41e-05	0.000256	CcSEcCtD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.41e-05	0.00147	CbGpPWpGaD
Sertraline—Gastrointestinal disorder—Betaxolol—glaucoma	4.41e-05	0.000256	CcSEcCtD
Sertraline—Fatigue—Betaxolol—glaucoma	4.4e-05	0.000255	CcSEcCtD
Sertraline—Constipation—Betaxolol—glaucoma	4.36e-05	0.000253	CcSEcCtD
Sertraline—Pain—Betaxolol—glaucoma	4.36e-05	0.000253	CcSEcCtD
Sertraline—Nausea—Pilocarpine—glaucoma	4.36e-05	0.000253	CcSEcCtD
Sertraline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.35e-05	0.00146	CbGpPWpGaD
Sertraline—Arthralgia—Timolol—glaucoma	4.35e-05	0.000253	CcSEcCtD
Sertraline—Myalgia—Timolol—glaucoma	4.35e-05	0.000253	CcSEcCtD
Sertraline—Chest pain—Timolol—glaucoma	4.35e-05	0.000253	CcSEcCtD
Sertraline—Anxiety—Timolol—glaucoma	4.33e-05	0.000252	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	4.32e-05	0.000251	CcSEcCtD
Sertraline—Hypersensitivity—Clonidine—glaucoma	4.32e-05	0.000251	CcSEcCtD
Sertraline—Discomfort—Timolol—glaucoma	4.3e-05	0.000249	CcSEcCtD
Sertraline—Dry mouth—Timolol—glaucoma	4.25e-05	0.000247	CcSEcCtD
Sertraline—Asthenia—Clonidine—glaucoma	4.21e-05	0.000244	CcSEcCtD
Sertraline—Feeling abnormal—Betaxolol—glaucoma	4.21e-05	0.000244	CcSEcCtD
Sertraline—Confusional state—Timolol—glaucoma	4.2e-05	0.000244	CcSEcCtD
Sertraline—CYP2B6—Biological oxidations—CYP1B1—glaucoma	4.18e-05	0.0014	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CA2—glaucoma	4.18e-05	0.0014	CbGpPWpGaD
Sertraline—Anaphylactic shock—Timolol—glaucoma	4.17e-05	0.000242	CcSEcCtD
Sertraline—Oedema—Timolol—glaucoma	4.17e-05	0.000242	CcSEcCtD
Sertraline—Pruritus—Clonidine—glaucoma	4.15e-05	0.000241	CcSEcCtD
Sertraline—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	4.12e-05	0.00138	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—FAS—glaucoma	4.12e-05	0.00138	CbGpPWpGaD
Sertraline—Shock—Timolol—glaucoma	4.1e-05	0.000238	CcSEcCtD
Sertraline—Nervous system disorder—Timolol—glaucoma	4.09e-05	0.000237	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—C3—glaucoma	4.06e-05	0.00136	CbGpPWpGaD
Sertraline—Urticaria—Betaxolol—glaucoma	4.05e-05	0.000235	CcSEcCtD
Sertraline—Skin disorder—Timolol—glaucoma	4.05e-05	0.000235	CcSEcCtD
Sertraline—Body temperature increased—Betaxolol—glaucoma	4.03e-05	0.000234	CcSEcCtD
Sertraline—Hyperhidrosis—Timolol—glaucoma	4.03e-05	0.000234	CcSEcCtD
Sertraline—Diarrhoea—Clonidine—glaucoma	4.01e-05	0.000233	CcSEcCtD
Sertraline—Anorexia—Timolol—glaucoma	3.97e-05	0.000231	CcSEcCtD
Sertraline—CYP2C19—Biological oxidations—GSTT1—glaucoma	3.96e-05	0.00133	CbGpPWpGaD
Sertraline—Hypotension—Timolol—glaucoma	3.9e-05	0.000226	CcSEcCtD
Sertraline—Dizziness—Clonidine—glaucoma	3.88e-05	0.000225	CcSEcCtD
Sertraline—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	3.82e-05	0.00128	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Timolol—glaucoma	3.8e-05	0.000221	CcSEcCtD
Sertraline—Insomnia—Timolol—glaucoma	3.77e-05	0.000219	CcSEcCtD
Sertraline—Hypersensitivity—Betaxolol—glaucoma	3.76e-05	0.000218	CcSEcCtD
Sertraline—Paraesthesia—Timolol—glaucoma	3.74e-05	0.000217	CcSEcCtD
Sertraline—Vomiting—Clonidine—glaucoma	3.73e-05	0.000216	CcSEcCtD
Sertraline—Dyspnoea—Timolol—glaucoma	3.72e-05	0.000216	CcSEcCtD
Sertraline—Somnolence—Timolol—glaucoma	3.71e-05	0.000215	CcSEcCtD
Sertraline—Rash—Clonidine—glaucoma	3.7e-05	0.000215	CcSEcCtD
Sertraline—Dermatitis—Clonidine—glaucoma	3.69e-05	0.000214	CcSEcCtD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.69e-05	0.00123	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NARFL—glaucoma	3.68e-05	0.00123	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CA5A—glaucoma	3.68e-05	0.00123	CbGpPWpGaD
Sertraline—Headache—Clonidine—glaucoma	3.67e-05	0.000213	CcSEcCtD
Sertraline—Dyspepsia—Timolol—glaucoma	3.67e-05	0.000213	CcSEcCtD
Sertraline—Asthenia—Betaxolol—glaucoma	3.66e-05	0.000213	CcSEcCtD
Sertraline—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.65e-05	0.00122	CbGpPWpGaD
Sertraline—Decreased appetite—Timolol—glaucoma	3.62e-05	0.00021	CcSEcCtD
Sertraline—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.61e-05	0.00121	CbGpPWpGaD
Sertraline—Pruritus—Betaxolol—glaucoma	3.61e-05	0.00021	CcSEcCtD
Sertraline—Gastrointestinal disorder—Timolol—glaucoma	3.6e-05	0.000209	CcSEcCtD
Sertraline—Fatigue—Timolol—glaucoma	3.59e-05	0.000209	CcSEcCtD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	3.59e-05	0.0012	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.58e-05	0.0012	CbGpPWpGaD
Sertraline—Pain—Timolol—glaucoma	3.57e-05	0.000207	CcSEcCtD
Sertraline—Diarrhoea—Betaxolol—glaucoma	3.49e-05	0.000203	CcSEcCtD
Sertraline—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.49e-05	0.00117	CbGpPWpGaD
Sertraline—Nausea—Clonidine—glaucoma	3.48e-05	0.000202	CcSEcCtD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	3.48e-05	0.00116	CbGpPWpGaD
Sertraline—Feeling abnormal—Timolol—glaucoma	3.44e-05	0.000199	CcSEcCtD
Sertraline—Gastrointestinal pain—Timolol—glaucoma	3.41e-05	0.000198	CcSEcCtD
Sertraline—Dizziness—Betaxolol—glaucoma	3.38e-05	0.000196	CcSEcCtD
Sertraline—CYP1A2—Phase II conjugation—GSTM1—glaucoma	3.36e-05	0.00112	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—GSTM1—glaucoma	3.34e-05	0.00112	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.33e-05	0.00111	CbGpPWpGaD
Sertraline—Urticaria—Timolol—glaucoma	3.31e-05	0.000192	CcSEcCtD
Sertraline—Body temperature increased—Timolol—glaucoma	3.3e-05	0.000191	CcSEcCtD
Sertraline—Abdominal pain—Timolol—glaucoma	3.3e-05	0.000191	CcSEcCtD
Sertraline—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	3.3e-05	0.0011	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.27e-05	0.00109	CbGpPWpGaD
Sertraline—Vomiting—Betaxolol—glaucoma	3.25e-05	0.000188	CcSEcCtD
Sertraline—Rash—Betaxolol—glaucoma	3.22e-05	0.000187	CcSEcCtD
Sertraline—Dermatitis—Betaxolol—glaucoma	3.22e-05	0.000187	CcSEcCtD
Sertraline—Headache—Betaxolol—glaucoma	3.2e-05	0.000186	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	3.19e-05	0.00107	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.16e-05	0.00106	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.13e-05	0.00105	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.12e-05	0.00104	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTT1—glaucoma	3.09e-05	0.00103	CbGpPWpGaD
Sertraline—Hypersensitivity—Timolol—glaucoma	3.07e-05	0.000178	CcSEcCtD
Sertraline—Nausea—Betaxolol—glaucoma	3.03e-05	0.000176	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	3.02e-05	0.00101	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	3.02e-05	0.00101	CbGpPWpGaD
Sertraline—Asthenia—Timolol—glaucoma	2.99e-05	0.000174	CcSEcCtD
Sertraline—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	2.98e-05	0.000997	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.95e-05	0.000987	CbGpPWpGaD
Sertraline—Pruritus—Timolol—glaucoma	2.95e-05	0.000171	CcSEcCtD
Sertraline—MAOB—Metabolism—TXN—glaucoma	2.94e-05	0.000984	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP1B1—glaucoma	2.91e-05	0.000971	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.88e-05	0.000963	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CA1—glaucoma	2.87e-05	0.000959	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.87e-05	0.000958	CbGpPWpGaD
Sertraline—Diarrhoea—Timolol—glaucoma	2.85e-05	0.000166	CcSEcCtD
Sertraline—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.84e-05	0.00095	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NARFL—glaucoma	2.78e-05	0.000929	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CA5A—glaucoma	2.78e-05	0.000929	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CTSA—glaucoma	2.78e-05	0.000928	CbGpPWpGaD
Sertraline—Dizziness—Timolol—glaucoma	2.76e-05	0.00016	CcSEcCtD
Sertraline—ABCB1—Metabolism—CA5A—glaucoma	2.71e-05	0.000907	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NARFL—glaucoma	2.71e-05	0.000907	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.69e-05	0.0009	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	2.68e-05	0.000896	CbGpPWpGaD
Sertraline—Vomiting—Timolol—glaucoma	2.65e-05	0.000154	CcSEcCtD
Sertraline—Rash—Timolol—glaucoma	2.63e-05	0.000153	CcSEcCtD
Sertraline—Dermatitis—Timolol—glaucoma	2.63e-05	0.000152	CcSEcCtD
Sertraline—MAOA—Metabolism—CA2—glaucoma	2.62e-05	0.000877	CbGpPWpGaD
Sertraline—Headache—Timolol—glaucoma	2.61e-05	0.000152	CcSEcCtD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.59e-05	0.000867	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.56e-05	0.000857	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CA5A—glaucoma	2.56e-05	0.000855	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NARFL—glaucoma	2.56e-05	0.000855	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NARFL—glaucoma	2.53e-05	0.000847	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CA5A—glaucoma	2.53e-05	0.000847	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.53e-05	0.000844	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	2.51e-05	0.000839	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.49e-05	0.000833	CbGpPWpGaD
Sertraline—Nausea—Timolol—glaucoma	2.48e-05	0.000144	CcSEcCtD
Sertraline—CYP1A2—Biological oxidations—CYP1B1—glaucoma	2.46e-05	0.000823	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	2.43e-05	0.000812	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.39e-05	0.000799	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.38e-05	0.000797	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.37e-05	0.000794	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.35e-05	0.000788	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.32e-05	0.000777	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.3e-05	0.00077	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.3e-05	0.000769	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.29e-05	0.000766	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTT1—glaucoma	2.28e-05	0.000763	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.27e-05	0.000759	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.22e-05	0.000742	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	2.2e-05	0.000734	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NARFL—glaucoma	2.16e-05	0.000724	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CA5A—glaucoma	2.16e-05	0.000724	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.15e-05	0.000719	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.15e-05	0.000719	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.04e-05	0.000682	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.03e-05	0.000679	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTM1—glaucoma	1.97e-05	0.000658	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	1.94e-05	0.000649	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—glaucoma	1.93e-05	0.000645	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.9e-05	0.000635	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.87e-05	0.000626	CbGpPWpGaD
Sertraline—MAOA—Metabolism—TXN—glaucoma	1.85e-05	0.000618	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP1B1—glaucoma	1.82e-05	0.000608	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ABCA1—glaucoma	1.82e-05	0.000608	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CA1—glaucoma	1.8e-05	0.0006	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—TNF—glaucoma	1.75e-05	0.000585	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CTSA—glaucoma	1.74e-05	0.000582	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.74e-05	0.000581	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NARFL—glaucoma	1.67e-05	0.000559	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CA5A—glaucoma	1.67e-05	0.000559	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CA2—glaucoma	1.64e-05	0.000549	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.62e-05	0.000543	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.52e-05	0.000508	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.5e-05	0.000501	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTM1—glaucoma	1.45e-05	0.000486	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTT1—glaucoma	1.43e-05	0.000479	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CA1—glaucoma	1.36e-05	0.000454	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CA1—glaucoma	1.32e-05	0.000443	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CTSA—glaucoma	1.31e-05	0.000439	CbGpPWpGaD
Sertraline—MAOB—Metabolism—MTHFR—glaucoma	1.28e-05	0.00043	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CTSA—glaucoma	1.28e-05	0.000429	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.28e-05	0.000427	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CA1—glaucoma	1.25e-05	0.000417	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CA2—glaucoma	1.24e-05	0.000415	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CA1—glaucoma	1.24e-05	0.000414	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.21e-05	0.000406	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.21e-05	0.000406	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CA2—glaucoma	1.21e-05	0.000405	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.21e-05	0.000405	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CTSA—glaucoma	1.21e-05	0.000404	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CTSA—glaucoma	1.2e-05	0.000401	CbGpPWpGaD
Sertraline—MAOB—Metabolism—APOE—glaucoma	1.2e-05	0.0004	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CAV1—glaucoma	1.19e-05	0.000396	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TXN—glaucoma	1.16e-05	0.000387	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CA2—glaucoma	1.14e-05	0.000382	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ABCA1—glaucoma	1.14e-05	0.000382	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP1B1—glaucoma	1.14e-05	0.000382	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CA2—glaucoma	1.13e-05	0.000378	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.11e-05	0.00037	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.11e-05	0.00037	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CA1—glaucoma	1.06e-05	0.000354	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CTSA—glaucoma	1.02e-05	0.000342	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.01e-05	0.000337	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CA2—glaucoma	9.67e-06	0.000323	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.45e-06	0.000316	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.45e-06	0.000316	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTM1—glaucoma	9.12e-06	0.000305	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTT1—glaucoma	8.97e-06	0.0003	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NOS3—glaucoma	8.96e-06	0.0003	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TXN—glaucoma	8.74e-06	0.000292	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.63e-06	0.000288	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TXN—glaucoma	8.53e-06	0.000285	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTGS2—glaucoma	8.2e-06	0.000274	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CA1—glaucoma	8.16e-06	0.000273	CbGpPWpGaD
Sertraline—MAOA—Metabolism—MTHFR—glaucoma	8.06e-06	0.00027	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TXN—glaucoma	8.04e-06	0.000269	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.98e-06	0.000267	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TXN—glaucoma	7.97e-06	0.000267	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.9e-06	0.000264	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CTSA—glaucoma	7.9e-06	0.000264	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.6e-06	0.000254	CbGpPWpGaD
Sertraline—MAOA—Metabolism—APOE—glaucoma	7.51e-06	0.000251	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CA2—glaucoma	7.46e-06	0.00025	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CAV1—glaucoma	7.44e-06	0.000249	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.27e-06	0.000243	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.21e-06	0.000241	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ABCA1—glaucoma	7.15e-06	0.000239	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP1B1—glaucoma	7.15e-06	0.000239	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TXN—glaucoma	6.81e-06	0.000228	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTT1—glaucoma	6.78e-06	0.000227	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTT1—glaucoma	6.62e-06	0.000221	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTT1—glaucoma	6.24e-06	0.000209	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.22e-06	0.000208	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTT1—glaucoma	6.18e-06	0.000207	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.16e-06	0.000206	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTM1—glaucoma	5.71e-06	0.000191	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NOS3—glaucoma	5.62e-06	0.000188	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.47e-06	0.000183	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP1B1—glaucoma	5.4e-06	0.000181	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ABCA1—glaucoma	5.4e-06	0.000181	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTT1—glaucoma	5.28e-06	0.000177	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ABCA1—glaucoma	5.27e-06	0.000176	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP1B1—glaucoma	5.27e-06	0.000176	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TXN—glaucoma	5.26e-06	0.000176	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS2—glaucoma	5.14e-06	0.000172	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—MTHFR—glaucoma	5.05e-06	0.000169	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.98e-06	0.000167	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP1B1—glaucoma	4.97e-06	0.000166	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ABCA1—glaucoma	4.97e-06	0.000166	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ABCA1—glaucoma	4.93e-06	0.000165	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP1B1—glaucoma	4.93e-06	0.000165	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—APOE—glaucoma	4.7e-06	0.000157	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CAV1—glaucoma	4.66e-06	0.000156	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTM1—glaucoma	4.32e-06	0.000144	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.26e-06	0.000142	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTM1—glaucoma	4.21e-06	0.000141	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ABCA1—glaucoma	4.21e-06	0.000141	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP1B1—glaucoma	4.21e-06	0.000141	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTT1—glaucoma	4.08e-06	0.000136	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTM1—glaucoma	3.97e-06	0.000133	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTM1—glaucoma	3.94e-06	0.000132	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—MTHFR—glaucoma	3.82e-06	0.000128	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—MTHFR—glaucoma	3.72e-06	0.000125	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—APOE—glaucoma	3.55e-06	0.000119	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NOS3—glaucoma	3.52e-06	0.000118	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CAV1—glaucoma	3.52e-06	0.000118	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—MTHFR—glaucoma	3.51e-06	0.000117	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—MTHFR—glaucoma	3.48e-06	0.000116	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—APOE—glaucoma	3.47e-06	0.000116	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CAV1—glaucoma	3.44e-06	0.000115	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTM1—glaucoma	3.36e-06	0.000113	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—APOE—glaucoma	3.27e-06	0.000109	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP1B1—glaucoma	3.25e-06	0.000109	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ABCA1—glaucoma	3.25e-06	0.000109	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—APOE—glaucoma	3.24e-06	0.000108	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CAV1—glaucoma	3.24e-06	0.000108	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS2—glaucoma	3.22e-06	0.000108	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CAV1—glaucoma	3.21e-06	0.000107	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—MTHFR—glaucoma	2.97e-06	9.94e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—APOE—glaucoma	2.77e-06	9.26e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CAV1—glaucoma	2.74e-06	9.17e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NOS3—glaucoma	2.66e-06	8.9e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NOS3—glaucoma	2.6e-06	8.69e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTM1—glaucoma	2.6e-06	8.68e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NOS3—glaucoma	2.45e-06	8.19e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS2—glaucoma	2.43e-06	8.14e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NOS3—glaucoma	2.43e-06	8.12e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS2—glaucoma	2.38e-06	7.95e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—MTHFR—glaucoma	2.29e-06	7.67e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS2—glaucoma	2.24e-06	7.49e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS2—glaucoma	2.22e-06	7.42e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—APOE—glaucoma	2.14e-06	7.14e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CAV1—glaucoma	2.12e-06	7.08e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NOS3—glaucoma	2.07e-06	6.94e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS2—glaucoma	1.9e-06	6.34e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NOS3—glaucoma	1.6e-06	5.35e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS2—glaucoma	1.46e-06	4.9e-05	CbGpPWpGaD
